Show/hide main menu

Addictions Department Staff

Dr Nicola Metrebian

Senior Research Fellow

PhD

Email: Nicola.Metrebian@kcl.ac.uk

N MetrebianNicola Metrebian is a Senior Research Fellow in the Addictions Department. Nicola joined King’s in 2005 having previously worked at Imperial College. She has a background in Psychology and a PhD from Imperial. Her research interests include pharmacological and psychological interventions for individuals with opiate dependence. Her first study at King’s was evaluating supervised injectable opiate treatment for hard to treat heroin users (RIOTT). She is currently the Programme Manager for a NIHR Programme Grant to assess the use of contingency management (financial incentives) in UK addiction treatment. The programme grant includes two large cluster RCTs examining the effectiveness of using contingency management (financial incentives) to: 1) improve the completion rates of hepatitis B vaccination among individuals receiving opiate substitution treatment (CONMAN) and most recently 2) to encourage abstinence from street heroin among individuals receiving opiate substitution treatment (PRAISe).  In 2015 she received an EMCDDA Scientific Paper award for her paper published in the Lancet reporting on the benefits of using small financial incentives to encourage the completion of hepatitis B vaccination among individuals receiving opiate treatment. 

 

Nicola is a member and a Chair of the Addictions Department's Diversity & Inclusion Working Group. 

Recent Publications

Strang J, Groshkova T, Uchtenhagen A, van den Brink W, Haasen C, Schechter M T, Lintzeris N, Bell J, Pirona A, Oviedo-Joekes E, Simon R & Metrebian N. Heroin on trial: Systematic review and meta-analysis of randomised trials of diamorphine prescribing as treatment for refractory heroin addiction. The British Journal of Psychiatry 2015: 207, 5-14.

Weaver T, Metrebian N, Strang J. Correspondence. Use of contingency management incentives to improve completion of hepatitis B vaccination in people undergoing treatment for heroin dependence: a cluster randomised trial. Lancet 2015; 385:116.

Metrebian, N Groshkova, T, Hellier J, Charles V, Martin A, Forzisi L, Lintzeris N, Zador D, Williams H, Carnwath T, Mayet S and Strang J. Drug Use, health and social outcomes of hard to treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomised Injectable Opioid Treatment Trial (RIOTT). Addiction 2014; 10.1111/add.12748

Weaver T*, Metrebian N*, Hellier J, Pilling S, Charles V, Little N, Poovendran D, Mitcheson L, Ryan F, Bowden-Jones O, Dunn J, Glasper A, Finch E, Strang J. Use of contingency management incentives to improve completion of hepatitis B vaccination in people undergoing treatment for heroin dependence: a cluster randomised trial. Lancet 2014; 384:153-63. (* joint first authors)

Byford S, Barrett B, Metrebian N, Groshkova T, Cary M, Charles V, Lintzeris N, Strang J. Correspondence. The British Journal of Psychiatry 2014; 204,3, p241-242

Strang J, Groshkova T and Metrebian N. New Heroin-Assisted Treatment: Recent evidence and current practices of supervised injectable heroin treatment in Europe and beyond. EMCDDA Insight series 11

Groshkova, T; Metrebian, N; Hallam, C; Charles, V; Martin, A, Forzisi, L; Lintzeris, N and Strang J. Treatment expectations and satisfaction of treatment-refractory opioid-dependent patients in RIOTT, the Randomised Injectable Opiate Treatment Trial, the UK’s first supervised injectable maintenance clinics. Drug and Alcohol Review 2013; 32, 566-573

Byford S, Barrett B, Metrebian N, Groshkova T, Cary M, Charles V, Lintzeris N and Strang J. Cost-effectiveness of injectable opioid treatment v. oral methadone for chronic heroin addiction. The British Journal of Psychiatry 2013; 203:341-349.

Strang J, Metrebian N, Lintzeris N, Potts L, Carnwath T, Mayet S, et al (2010) Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT) : a randomised trial. Lancet 375: 1885-95

Miller P, Forzisi L, Lintzeris N, Zador D, Metrebian N, Strang J. (2009) Groin Injecting in Injectable Opioid Treatment Service Users in South London Addiction Research and Theory2009; 17(4):381-389.

Metrebian N., Sell L., Shanahan W., Carnwath T., Alcorn R., Ruben S., Mehdikhani M and Stimson GV. (2009) Prescribing Injectable Opiates in MacGregor S (Ed) Responding to Drugs Misuse: research and policy priorities in health and social care. Routledge (2009)

Weaver T, Goyder J, Hart J, Fehler J, Metrebian N & Crawford M. Care Co-ordination in Drug Treatment Services in MacGregor S (Ed) Responding to Drugs Misuse: research and policy priorities in health and social care. Routledge (2009)

Zador D, Lintzeris N, van der Waal R, Miller P, Metrebian N, Strang J.(2008) The fine line between harm reduction and harm production – development of a clinical policy on femoral (groin) injecting European Addiction Research Journal; 14; 213-218

Metrebian N, Mott J, Carnwath Z, Carnwath T & Stimson GV. (2007) Pathways into receiving a prescription for diamorphine (heroin) for the treatment of opiate dependence in the United Kingdom. European Addiction Research2007;13:144-147

Lintzeris N, Strang J, Metrebian N, Byford S, Hallam C, Lee S and RIOTT Group. (2006) Methodology for the Randomised Injecting Opioid Treatment Trial (RIOTT): evaluating injectable methadone and heroin treatment versus optimised oral methadone treatment in the UK. Harm Reduction Journal 2006, 3:28

Metrebian N, Carnwath Z, Mott J, Carnwath T & Stimson GV. (2006) Patients receiving a prescription for diamorphine (heroin) in the United Kingdom. Drug and Alcohol Review 2006, 25:115-121

N Metrebian, G V Stimson, W Shanahan, R Alcorn, L Sell, A Nunn, R Gabe, M Knapp, S Byford, D Epstein, S Thompson, M Medhikhani, D Harley, M Medjesi-Jones, G Campbell, T Carnwath, S Ruben (2005) 'Pilot UK-injectable methadone trial (pilot UK-INJECT)' Drugs: Education, Prevention and Policy, 12, pp. 111-114.

Stimson GV & Metrebian N (2003) Prescribing heroin: what is the evidence? Joseph Rowntree Foundation Drug and Alcohol Research Programme. Joseph Rowntree Foundation.

Metrebian N, Carnwath T, Stimson GV and Soltz T (2002) Survey of doctors prescribing diamorphine (heroin) to opiate dependent drug users in the United Kingdom Addiction 2002; 97; 1155-1161

Fischer, B, Rehm J, Kirst M, Casas M, Hall W, Krausz M, Metrebian N, et al (2002) Heroin assisted treatment as a response to the public health problem of opiate dependence in established market economics – an overview, European Journal of Public Health 2002;12; 228-234

Metrebian Net al (2001) Prescribing drug of choice to opiate dependent drug users : a comparison of clients receiving heroin with those receiving injectable methadone at a West London drug clinic. Drug and Alcohol Review 2001; 20, 267-276.

Metrebian N and Stimson GV. (2000) Heroin prescribing in the UK: Lost opportunities for research? Addiction Research 2000; 8, 4: 305-310

Sitemap Site help Terms and conditions  Privacy policy  Accessibility  Modern slavery statement  Contact us

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454